December 27, 2019 — The U.S.
Deep Vein Thrombosis (DVT)
Deep vein thrombosis (DVT) is caused by the formation of venous blood clots in the arms and legs. This page includes information on technologies to treat DVT using catheter based interventions and thrombolysis.
-
-
May 17, 2019 — The U.S.
-
May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for the treatment of iliofemoral venous obstructive disease.
-
Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but declined rapidly after several large trials showed no benefit.
The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).
Feature | Antiplatelet and Anticoagulation Therapies | December 27, 2019
December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics...
The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels.
News | Deep Vein Thrombosis (DVT) | November 14, 2019
November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following...
Fragmin (dalteparin sodium) injection is now cleared by the FDA for use in pediatric patients. It was initially approved by the FDA in 1994 for adults and is a type of heparin.
Technology | Antiplatelet and Anticoagulation Therapies | May 17, 2019
May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection...
Illustration showing the self-expanding deployment of the Vici stent in the iliofemoral vein.
Technology | Venous Therapies | May 06, 2019
May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System...
News | Thrombectomy Devices | February 12, 2019
February 12, 2019 — A study presented at the 2018 annual meeting of the Cardiovascular and Interventional Radiology...
An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal.
Feature | Thrombectomy Devices | January 22, 2019 | Dave Fornell, Editor
Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but...
News | Thrombectomy Devices | November 21, 2018
November 21, 2018 — BTG plc announced the first Ekos CU 4.0 units have been shipped from BTG’s facility in Bothell,...
Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot.
Feature | Deep Vein Thrombosis (DVT) | February 16, 2018 | Sanjay Pandya, M.D.
There are few downsides to using tibial venous access to treat...
News | Venous Therapies | January 26, 2018
January 26, 2018 – Medtronic plc announced the initiation of its investigational device exemption (IDE) study for...
News | Deep Vein Thrombosis (DVT) | July 07, 2017
July 7, 2017 — BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for...
Videos | Venous Therapies | June 27, 2017
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein...
Technology | Pulmonary Embolism | March 01, 2017
March 1, 2017 — BTG plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance has been granted to the...
News | Thrombectomy Devices | January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
News | Analytics Software | October 31, 2016
October 31, 2016 — In an effort to improve patient care, Children's Hospital of Philadelphia's (CHOP) Information...
Technology | Stents Peripheral | April 27, 2016
April 27, 2016 — Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a...
